theophylline has been researched along with cephalexin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gubernator, K; Kansy, M; Senner, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Botta, M; Dreassi, E; Falchi, F; Maga, G; Santucci, A; Schenone, S; Zizzari, AT | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Friedman, P; Greenblatt, DJ; Pfeifer, HJ | 1 |
| Abate, MA; Hammond, D | 1 |
| Bachmann, K; Forney, RB; Jauregui, L; Schwartz, J | 1 |
| Hempenius, J; Holtkamp, A; Jonkman, JH; Schoenmaker, R; van der Boon, WJ | 2 |
| Haruta, S; Higaki, K; Kimura, T; Kurosaki, Y; Sawamoto, T | 1 |
| Haruta, S; Higaki, K; Iwasaki, N; Kimura, T; Ogawara, K | 1 |
| Barbero, N; Pontremoli, C; Viscardi, G; Visentin, S | 1 |
1 review(s) available for theophylline and cephalexin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for theophylline and cephalexin
| Article | Year |
|---|---|
Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.
Topics: Absorption; Adsorption; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Permeability; Pharmacokinetics; Spectrophotometry, Ultraviolet | 1998 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.
Topics: Humans; Lipids; Membranes, Artificial; Permeability; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrimidines | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effects of three antibiotics on theophylline kinetics.
Topics: Adult; Aminophylline; Cephalexin; Drug Interactions; Erythromycin; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Tetracycline; Theophylline | 1979 |
Theophylline toxicity, acute illness, and cefaclor administration.
Topics: Acute Disease; Cefaclor; Cephalexin; Child; Drug Interactions; Humans; Male; Theophylline; Virus Diseases | 1989 |
Impact of cefaclor on the pharmacokinetics of theophylline.
Topics: Adult; Cefaclor; Cephalexin; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Theophylline | 1986 |
Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
Topics: Adult; Cefaclor; Cephalexin; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Theophylline; Time Factors | 1986 |
No effect of cefaclor on theophylline pharmacokinetics.
Topics: Adult; Cefaclor; Cephalexin; Female; Humans; Kinetics; Male; Theophylline | 1985 |
Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability.
Topics: Administration, Oral; Ampicillin; Animals; Area Under Curve; Biological Availability; Cephalexin; Cephalosporins; Chromatography, High Pressure Liquid; Gastrointestinal Transit; Intestinal Absorption; Male; Penicillins; Pharmacokinetics; Phenolsulfonphthalein; Propranolol; Rats; Rats, Wistar; Theophylline; Vasodilator Agents | 1997 |
Absorption behavior of orally administered drugs in rats treated with propantheline.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Area Under Curve; Bronchodilator Agents; Cephalexin; Gastrointestinal Motility; Intestinal Absorption; Male; Models, Biological; Muscarinic Antagonists; Propantheline; Rats; Rats, Wistar; Theophylline | 1998 |
Mucin-drugs interaction: The case of theophylline, prednisolone and cephalexin.
Topics: Animals; Binding Sites; Cephalexin; Molecular Structure; Mucins; Prednisolone; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Stomach; Swine; Theophylline; Thermodynamics | 2015 |